S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
Log in

Concert Pharmaceuticals News Headlines (NASDAQ:CNCE)

$11.11
-0.59 (-5.04 %)
(As of 02/20/2020 04:00 PM ET)
Today's Range
$10.97
Now: $11.11
$11.89
50-Day Range
$9.20
MA: $10.63
$13.09
52-Week Range
$5.36
Now: $11.11
$17.83
Volume170,993 shs
Average Volume211,132 shs
Market Capitalization$328.59 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05

Headlines

Concert Pharmaceuticals (NASDAQ CNCE) News Headlines

Source:
DateHeadline
Concert Pharmaceuticals to Report Full Year 2019 Results on February 27, 2020Concert Pharmaceuticals to Report Full Year 2019 Results on February 27, 2020
finance.yahoo.com - February 20 at 9:29 AM
Insider Buying: Concert Pharmaceuticals Inc (NASDAQ:CNCE) Director Purchases 1,000 Shares of StockInsider Buying: Concert Pharmaceuticals Inc (NASDAQ:CNCE) Director Purchases 1,000 Shares of Stock
www.americanbankingnews.com - February 4 at 12:36 PM
Concert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesConcert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - January 30 at 7:23 PM
Concert Pharmaceuticals Inc (NASDAQ:CNCE) Receives Average Rating of "Buy" from BrokeragesConcert Pharmaceuticals Inc (NASDAQ:CNCE) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 29 at 2:11 PM
Concert Pharmaceuticals (NASDAQ:CNCE) Rating Reiterated by MizuhoConcert Pharmaceuticals (NASDAQ:CNCE) Rating Reiterated by Mizuho
www.americanbankingnews.com - January 29 at 7:27 AM
Concert Pharma +6% on pricing equity offeringConcert Pharma +6% on pricing equity offering
seekingalpha.com - January 28 at 1:59 PM
Concert Pharmaceuticals Announces Pricing of Public OfferingConcert Pharmaceuticals Announces Pricing of Public Offering
finance.yahoo.com - January 28 at 1:59 PM
Concert Pharma wins reset on review of CTP-543 patentConcert Pharma wins reset on review of CTP-543 patent
seekingalpha.com - January 27 at 5:13 PM
Concert Pharma readies equity offering; shares down 1% after hoursConcert Pharma readies equity offering; shares down 1% after hours
seekingalpha.com - January 27 at 5:13 PM
Concert Pharmaceuticals Announces Federal Circuit Granted its Motion to Vacate and Remand PTAB Decision Involving CTP-543Concert Pharmaceuticals Announces Federal Circuit Granted its Motion to Vacate and Remand PTAB Decision Involving CTP-543
finance.yahoo.com - January 27 at 5:13 PM
Concert Pharmaceuticals Announces Proposed Public Offering of Common StockConcert Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 27 at 5:13 PM
SunTrust Banks Equities Analysts Decrease Earnings Estimates for Concert Pharmaceuticals Inc (NASDAQ:CNCE)SunTrust Banks Equities Analysts Decrease Earnings Estimates for Concert Pharmaceuticals Inc (NASDAQ:CNCE)
www.americanbankingnews.com - January 27 at 3:12 AM
Should You Be Concerned About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Historical Volatility?Should You Be Concerned About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Historical Volatility?
finance.yahoo.com - January 24 at 7:29 AM
Concert Pharma nabs new CTP-543 patent; shares ahead 4%Concert Pharma nabs new CTP-543 patent; shares ahead 4%
seekingalpha.com - January 22 at 5:29 PM
Concert Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Related to CTP-543, Lead Candidate for Treatment of Alopecia AreataConcert Pharmaceuticals Announces Notice of Allowance for U.S. Patent Application Related to CTP-543, Lead Candidate for Treatment of Alopecia Areata
finance.yahoo.com - January 22 at 5:29 PM
Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients with Alopecia AreataConcert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients with Alopecia Areata
finance.yahoo.com - December 19 at 5:36 PM
We Think Concert Pharmaceuticals (NASDAQ:CNCE) Needs To Drive Business Growth CarefullyWe Think Concert Pharmaceuticals (NASDAQ:CNCE) Needs To Drive Business Growth Carefully
finance.yahoo.com - December 16 at 7:14 AM
Do Hedge Funds Love Concert Pharmaceuticals  Inc (CNCE)?Do Hedge Funds Love Concert Pharmaceuticals Inc (CNCE)?
finance.yahoo.com - December 13 at 5:44 PM
Concert Pharmaceuticals Initiates CTP-692 Phase 2 Trial in SchizophreniaConcert Pharmaceuticals Initiates CTP-692 Phase 2 Trial in Schizophrenia
finance.yahoo.com - December 11 at 12:58 AM
Concert Pharma launches mid-stage study of CTP-692 in schizophreniaConcert Pharma launches mid-stage study of CTP-692 in schizophrenia
seekingalpha.com - December 2 at 12:30 PM
Edited Transcript of CNCE earnings conference call or presentation 7-Nov-19 1:30pm GMTEdited Transcript of CNCE earnings conference call or presentation 7-Nov-19 1:30pm GMT
finance.yahoo.com - November 15 at 7:37 AM
Concert Pharmaceuticals, Inc (CNCE) CEO Roger Tung on Q3 2019 Results - Earnings Call TranscriptConcert Pharmaceuticals, Inc (CNCE) CEO Roger Tung on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 2:07 AM
Should You Worry About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) CEO Salary Level?Should You Worry About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) CEO Salary Level?
finance.yahoo.com - November 10 at 11:05 AM
Concert Pharmaceuticals, Inc. (CNCE) Q3 2019 Earnings Call TranscriptConcert Pharmaceuticals, Inc. (CNCE) Q3 2019 Earnings Call Transcript
www.nasdaq.com - November 9 at 6:44 AM
Concert Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Company UpdateConcert Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Company Update
finance.yahoo.com - November 7 at 8:23 AM
Concert Pharmaceuticals to Host KOL Webcast Event Focused on CTP-692 and SchizophreniaConcert Pharmaceuticals to Host KOL Webcast Event Focused on CTP-692 and Schizophrenia
finance.yahoo.com - November 6 at 8:54 AM
Concert Pharmaceuticals Inc (CNCE) Is Burning These Hedge FundsConcert Pharmaceuticals Inc (CNCE) Is Burning These Hedge Funds
finance.yahoo.com - November 5 at 6:18 PM
Concert Pharmaceuticals  Inc (CNCE) Is Burning These Hedge FundsConcert Pharmaceuticals Inc (CNCE) Is Burning These Hedge Funds
finance.yahoo.com - November 5 at 6:18 PM
Analysts Estimate Concert Pharmaceuticals (CNCE) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Concert Pharmaceuticals (CNCE) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - October 31 at 2:16 PM
Concert Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 7, 2019Concert Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 7, 2019
finance.yahoo.com - October 31 at 8:26 AM
Concert Pharmaceuticals to Provide Overview of Clinical Pipeline at Cantor Healthcare ConferenceConcert Pharmaceuticals to Provide Overview of Clinical Pipeline at Cantor Healthcare Conference
finance.yahoo.com - October 2 at 7:49 AM
Concert stock falls 36 percent on Alzheimer's drug trial failureConcert stock falls 36 percent on Alzheimer's drug trial failure
finance.yahoo.com - September 27 at 4:27 PM
Did You Manage To Avoid Concert Pharmaceuticals's (NASDAQ:CNCE) 20% Share Price Drop?Did You Manage To Avoid Concert Pharmaceuticals's (NASDAQ:CNCE) 20% Share Price Drop?
finance.yahoo.com - September 19 at 3:20 PM
Patient enrollment completed in Concert Pharmas CTP-543 trial for alopecia areataPatient enrollment completed in Concert Pharma's CTP-543 trial for alopecia areata
seekingalpha.com - September 18 at 1:30 PM
Concert Pharmaceuticals Completes Enrollment in Second Open Label Trial of CTP-543 to Evaluate Once-Daily vs. Twice-Daily Dosing in Patients with Alopecia AreataConcert Pharmaceuticals Completes Enrollment in Second Open Label Trial of CTP-543 to Evaluate Once-Daily vs. Twice-Daily Dosing in Patients with Alopecia Areata
finance.yahoo.com - September 18 at 1:30 PM
Concert Gears Up For Late-Stage Study After Showing It Has The Goods For Treating Hair LossConcert Gears Up For Late-Stage Study After Showing It Has The Goods For Treating Hair Loss
seekingalpha.com - September 13 at 5:40 PM
Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV CongressConcert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV Congress
finance.yahoo.com - September 12 at 10:49 AM
Concert Pharma up 21% premarket on positive CTP-543 dataConcert Pharma up 21% premarket on positive CTP-543 data
seekingalpha.com - September 3 at 7:25 PM
What You Must Know About Concert Pharmaceuticals, Inc.s (NASDAQ:CNCE) Beta ValueWhat You Must Know About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Beta Value
finance.yahoo.com - August 16 at 7:55 PM
What You Must Know About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Beta ValueWhat You Must Know About Concert Pharmaceuticals, Inc.'s (NASDAQ:CNCE) Beta Value
finance.yahoo.com - August 16 at 7:55 PM
Concert Pharmaceuticals, Inc. (CNCE) Q2 2019 Earnings Call TranscriptConcert Pharmaceuticals, Inc. (CNCE) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 6 at 10:26 AM
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2019 Results - Earnings Call TranscriptConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 4 at 7:05 PM
Edited Transcript of CNCE earnings conference call or presentation 1-Aug-19 12:30pm GMTEdited Transcript of CNCE earnings conference call or presentation 1-Aug-19 12:30pm GMT
finance.yahoo.com - August 3 at 6:27 PM
Concert Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company UpdateConcert Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company Update
www.marketwatch.com - August 1 at 11:42 PM
Concert Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 1, 2019Concert Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 1, 2019
finance.yahoo.com - July 26 at 1:06 AM
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Insiders Increased Their HoldingsConcert Pharmaceuticals, Inc. (NASDAQ:CNCE) Insiders Increased Their Holdings
finance.yahoo.com - July 5 at 5:57 PM
Concert Pharmas CTP-692 Positive for Schizophrenia in Phase IConcert Pharma's CTP-692 Positive for Schizophrenia in Phase I
www.nasdaq.com - June 13 at 7:26 PM
Concert Pharmas CTP-692 shows favorable safety profile in early-stage studiesConcert Pharma's CTP-692 shows favorable safety profile in early-stage studies
seekingalpha.com - June 12 at 11:25 AM
Concert Pharmaceuticals Reports Positive Results from Phase 1 Studies Evaluating CTP-692 in Healthy VolunteersConcert Pharmaceuticals Reports Positive Results from Phase 1 Studies Evaluating CTP-692 in Healthy Volunteers
finance.yahoo.com - June 12 at 11:25 AM
Concert Pharmaceuticals (CNCE) Presents At Jefferies 2019 Healthcare Conference - SlideshowConcert Pharmaceuticals (CNCE) Presents At Jefferies 2019 Healthcare Conference - Slideshow
seekingalpha.com - June 7 at 4:34 PM
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel